High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-10-01
Series:Cells
Assuntos:
osteosarcoma
high-grade bone sarcoma
pediatric bone tumors
ifosfamide
chemotherapy
PARP1
Acceso en liña:https://www.mdpi.com/2073-4409/9/11/2389
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares